key: cord-0847253-1d7ufkfh authors: Sherman, William F.; Patel, Akshar H. title: Letter to the Editor: “Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous?” date: 2021-08-21 journal: Arthroplast Today DOI: 10.1016/j.artd.2021.07.010 sha: 955f9bcf07c6af5dee73e7bf670fdc0d3e1b3652 doc_id: 847253 cord_uid: 1d7ufkfh nan First, thank you to the authors for the very well written and educational article titled, Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous? While local complications such as prosthetic joint infection, periprosthetic fracture, aseptic loosening, and hematoma are common, systemic complications after elective total joint arthroplasty (TJA) also occur and include deep venous thrombosis, pulmonary embolism, myocardial infarction, cerebral vascular accident, renal failure, and, although rare, death [1e3]. With continued pressure to decrease complications from both clinical and cost standpoints, surgeons strive to optimize patients before surgery as risk factors for complications are well established [4] . There are risk factors for elective arthroplasty that are nonmodifiable such as age, sex, renal disease, rheumatologic disease, metastatic tumor, peripheral vascular disease, and valvular disease [4e6]. Most nonmodifiable risk factors can at least be optimized before elective arthroplasty; however, these risks continue to be present to some degree. Documented modifiable risk factors for TJA including diabetes control, elevated basal metabolic index (BMI), smoking or tobacco use, anemia, methicillin-resistant Staphylococcus aureus colonization status, and malnutrition [7e10]. The authors of this study reported in a large database that malnutrition, defined as hypoalbuminemia (<3.5), was the strongest risk factor for all complications evaluated [11] . It has been reported that individuals with obesity are at higher risk of complications; however, surgeons often indicate arthroplasty in patients with BMI over 40 for various reasons [12] . While there is debate regarding strict BMI cutoffs, insistence on smoking cessation, preoperative nutritional optimization, and HbA1C limits of 7.7 or less, the decision to offer a patient elective TJA is ultimately made by the surgeon taking into account the patient's entire risk profile and potential benefit of surgery [13, 14] . The World Health Organization (WHO) declared the outbreak of COVID-19 a global pandemic on March 11, 2020 [15] . Shortly after this declaration, many countries limited or ceased elective orthopedic cases including TJA [16] . With increased risks of thromboembolic disease associated with COVID-19, and association of increased complications in patients with comorbidities, restarting elective TJA has to be done ethically and responsibly [17, 18] . Patients with multiple comorbidities scheduled for elective TJA may be at higher risk of succumbing if infected with COVID-19 perioperatively and may also require inpatient recovery in rehabilitation units or nursing homes, further increasing the risk of transmission [16] . With a demonstrated higher complication rate in COVID-19positive patients undergoing hip fracture management, these studies highlight the importance of avoiding contraction during the perioperative period of the elective orthopedic surgery [19, 20] . With vaccines that may decrease a patient's symptoms or contractibility of COVID-19 and variants of COVID-19 readily available, the following question is now being raised: Is a nonvaccinated status a modifiable risk factor for TJA? Should surgeons offer elective TJA or other major elective hospital-based surgeries to patients without first requiring a COVID vaccine? With surgeons typically having a scheduling delay of at least 4 weeks before elective TJA, the recommendation of a vaccine as a preoperative prerequisite would have little impact on timing of surgery. With current COVID-19 testing protocols ranging within several days of the surgery to same-day testing, this could also decrease cancelations and improve efficient use of health-care resources. Owing to some hospitals now mandating that employees receive the COVID-19 vaccination leading to litigation and staff walkouts, there is the possibility for these large systems and payors to mandate patient vaccinations be done before elective cases which could lead to large disruptions. The answer to how to address this question will undoubtedly not receive unanimity but is currently being asked at local and regional levels and will potentially require orthopedic leadership to further bridge this discussion and research into the outcomes of COVID-19 vaccination status as an independent modifiable risk for arthroplasty and other major elective procedures. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article. Declining early mortality after hip and knee arthroplasty Hospital complications after total joint arthroplasty Complications following total hip arthroplasty: a nationwide database study comparing elective vs hip fracture cases Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA High level of residual symptoms in young patients after total knee arthroplasty knee Risk assessment for chronic pain and patient satisfaction after total knee arthroplasty on behalf of The American Association of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-ND license The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States Impact of diabetes on 90-day episodes of care after elective total joint arthroplasty among medicare beneficiaries Outcomes following hip and knee replacement in diabetic versus nondiabetic patients and well versus poorly controlled diabetic patients: a prospective cohort study Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital Failure to optimize before total knee arthroplasty: which modifiable risk factor is the Most dangerous? Surgeon decision-making for individuals with obesity when indicating total joint arthroplasty Determining the threshold for HbA1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study Editorial: the shortcomings and harms of using hard cutoffs for BMI, hemoglobin A1C, and smoking cessation as conditions for elective orthopaedic surgery Coronavirus disease 2019 (COVID-19) situation report e 51. 2020 Resuming hip and knee arthroplasty after COVID-19: ethical implications for wellbeing, safety and the economy Certain medical conditions and risk for severe COVID-19. Illness: CDC Hip fracture care during Covid-19: a regional trauma centre's experience Mortality escalates in patients of proximal femoral fractures with COVID-19: a systematic review and meta-analysis of 35 studies on 4255 patients